Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Parra RS, Chebli JMF, de Azevedo MFC, Chebli LA, Zabot GP, Cassol OS, de Sá Brito Fróes R, Santana GO, Lubini M, Magro DO, Imbrizi M, Moraes ACDS, Teixeira FV, Alves Junior AJT, Gasparetti Junior NLT, da Costa Ferreira S, Queiroz NSF, Kotze PG, Féres O. Parra RS, et al. Among authors: queiroz nsf. Crohns Colitis 360. 2024 Apr 11;6(2):otae023. doi: 10.1093/crocol/otae023. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38681979 Free PMC article.
Promoting equity in inflammatory bowel disease: a global approach to care.
Sebastian S, Siegmund B, Teferra F, McGovern DPB, Queiroz NSF, van der Woude CJ, Sharma V. Sebastian S, et al. Among authors: queiroz nsf. Lancet Gastroenterol Hepatol. 2024 Mar;9(3):192-194. doi: 10.1016/S2468-1253(23)00368-0. Epub 2024 Jan 11. Lancet Gastroenterol Hepatol. 2024. PMID: 38219765 No abstract available.
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Dotti AZ, Magro DO, Vilela EG, Chebli JMF, Chebli LA, Steinwurz F, Argollo M, Carvalho NS, Parente JML, Lima MM, Parra RS, Perin RL, Flores C, Morsoletto EM, da Costa Ferreira S, Ludvig JC, Kaiser Junior RL, Faria MAG, Nicollelli GM, Andrade AR, Queiroz NSF, Kotze PG. Dotti AZ, et al. Among authors: queiroz nsf. Crohns Colitis 360. 2023 Sep 22;5(4):otad053. doi: 10.1093/crocol/otad053. eCollection 2023 Oct. Crohns Colitis 360. 2023. PMID: 37859629 Free PMC article.
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus.
D'Amico F, Solitano V, Magro F, Olivera PA, Halfvarson J, Rubin D, Dignass A, Al Awadhi S, Kobayashi T, Queiroz NSF, Calvo M, Kotze PG, Ghosh S, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Among authors: queiroz nsf. J Clin Med. 2023 Oct 3;12(19):6350. doi: 10.3390/jcm12196350. J Clin Med. 2023. PMID: 37834994 Free PMC article.
Active tuberculosis in inflammatory bowel disease patients: a case-control study.
Freitas Cardoso de Azevedo M, Barros LL, Fernandes Justus F, Oba J, Soares Garcia K, de Almeida Martins C, de Sousa Carlos A, Arruda Leite AZ, Miranda Sipahi A, Queiroz NSF, Omar Mourão Cintra Damião A. Freitas Cardoso de Azevedo M, et al. Among authors: queiroz nsf. Therap Adv Gastroenterol. 2023 Jul 4;16:17562848231179871. doi: 10.1177/17562848231179871. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37435180 Free PMC article.
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial.
Garcia KS, de Azevedo MFC, Carlos AS, Barros LL, Oba J, Sobrado Junior CW, Sipahi AM, Alves ODC, Navarro-Rodriguez T, Parra RS, Chebli JMF, Chebli LA, Flores C, Vieira A, do Ceará CDA, Queiroz NSF, Damião AOMC. Garcia KS, et al. Among authors: queiroz nsf. Biomedicines. 2023 Jun 19;11(6):1757. doi: 10.3390/biomedicines11061757. Biomedicines. 2023. PMID: 37371853 Free PMC article.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Baima JP, Imbrizi M, Andrade AR, Chebli LA, Argollo MC, Queiroz NSF, Azevedo MFC, Vieira A, Costa MHM, Fróes RSB, Penna FGCE, Quaresma AB, Damião AOMC, Moraes ACDS, Santos CHMD, Flores C, Zaltman C, Vilela EG, Morsoletto E, Gonçalves Filho FA, Santana GO, Zabot GP, Parente JML, Sassaki LY, Zerôncio MA, Machado MB, Cassol OS, Kotze PG, Parra RS, Miszputen SJ, Coy CSR, Ambrogini Junior O, Chebli JMF, Saad-Hossne R. Baima JP, et al. Among authors: queiroz nsf. Arq Gastroenterol. 2023 Mar 24;59(suppl 1):51-84. doi: 10.1590/S0004-2803.2022005S1-03. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995889 Free article.
41 results